Innealta Capital’s Labcorp LH Stock Holding History

Innealta Capital’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-155	Closed	-$31.5K	–	1003
2024 Q2	$31.5K	Buy	+155	New	+$31.5K	0.01%	491

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Innealta Capital's LH Position: Q3 2024 in Review

Innealta Capital sold out of Labcorp (LH) in Q3 2024, closing a stake of 155 shares — an estimated $31.5K sold.

Innealta Capital first reported a position in LH in Q2 2024 and held it in 1 quarter. The position peaked at $31.5K in Q2 2024. 918 funds tracked by Wall St. Rank hold LH as of Q3 2024.

Innealta Capital reported no remaining Labcorp position as of Q3 2024 after selling out during the quarter.
Innealta Capital sold 155 Labcorp shares in Q3 2024, an estimated $31.5K.
Innealta Capital first reported a position in Labcorp in Q2 2024 and held it in 1 quarter.
Innealta Capital's Labcorp position peaked at $31.5K in Q2 2024.
918 funds tracked by Wall St. Rank held Labcorp as of Q3 2024.

Based on Innealta Capital's 13F filing for Q3 2024, filed 29 Oct 2024.